HLUN-A.CO
Price:
$29.85
Market Cap:
$26.83B
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-06-10
Stock Exchange
CPH
Ticker
HLUN-A.CO
According to H. Lundbeck A/S’s latest financial reports and current stock price. The company's current ROE is 13.61%. This represents a change of 299.72% compared to the average of 3.41% of the last 4 quarters.
The mean historical ROE of H. Lundbeck A/S over the last ten years is 6.37%. The current 13.61% ROE has changed 113.85% with respect to the historical average. Over the past ten years (40 quarters), HLUN-A.CO's ROE was at its highest in in the March 2018 quarter at 10.31%. The ROE was at its lowest in in the June 2015 quarter at -38.35%.
Average
6.37%
Median
11.44%
Minimum
-64.82%
Maximum
27.42%
Discovering the peaks and valleys of H. Lundbeck A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.63%
Maximum Annual ROE = 27.42%
Minimum Annual Increase = -119.27%
Minimum Annual ROE = -64.82%
Year | ROE | Change |
---|---|---|
2024 | 12.57% | 20.98% |
2023 | 10.39% | 12.66% |
2022 | 9.22% | 27.88% |
2021 | 7.21% | -22.59% |
2020 | 9.31% | -49.17% |
2019 | 18.32% | -33.16% |
2018 | 27.42% | 27.27% |
2017 | 21.54% | 72.44% |
2016 | 12.49% | -119.27% |
2015 | -64.82% | 5.63% |
The current ROE of H. Lundbeck A/S (HLUN-A.CO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.73%
5-year avg
9.74%
10-year avg
6.37%
H. Lundbeck A/S’s ROE is less than H. Lundbeck A/S (13.61%), less than GN Store Nord A/S (7.68%), less than Nordea Bank Abp (15.91%), less than FLSmidth & Co. A/S (10.20%), less than Tryg A/S (12.91%),
Company | ROE | Market cap |
---|---|---|
13.61% | $26.83B | |
7.68% | $14.57B | |
15.91% | $314.68B | |
10.20% | $22.49B | |
12.91% | $97.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like H. Lundbeck A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like H. Lundbeck A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is H. Lundbeck A/S's ROE?
How is the ROE calculated for H. Lundbeck A/S (HLUN-A.CO)?
What is the highest ROE for H. Lundbeck A/S (HLUN-A.CO)?
What is the 3-year average ROE for H. Lundbeck A/S (HLUN-A.CO)?
What is the 5-year average ROE for H. Lundbeck A/S (HLUN-A.CO)?
How does the current ROE for H. Lundbeck A/S (HLUN-A.CO) compare to its historical average?